NYSE: CLBCore Laboratories Inc Stock
$16.99+0.30 (+1.8%)
Updated Apr 18, 2024
CLB Price
$16.99
Fair Value Price
N/A
Market Cap
$796.09M
52 Week Low
$13.82
52 Week High
$27.95
P/E
21.51x
P/B
3.54x
P/S
1.62x
PEG
0.34x
Dividend Yield
0.24%
Revenue
$509.79M
Earnings
$36.68M
Gross Margin
21.5%
Operating Margin
10.65%
Profit Margin
7.2%
Debt to Equity
1.59
Operating Cash Flow
$25M
Beta
1.23
Next Earnings
Apr 24, 2024
Ex-Dividend
N/A
Next Dividend
N/A
CLB Overview
Core Laboratories N.V. provides core and fluid analysis to the oil and gas industry to increase production from its clients' reservoirs. Specialties include basic rock properties, core analysis, and PVT characterization of reservoir fluids. Analytical and field services characterize the properties of crude oil and integrated diagnostic services evaluate the effectiveness of well completions. Core Laboratories was founded in 1936 and is based in Amstelveen, the Netherlands.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CLB ($16.99) is trading below its intrinsic value of $21.64, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLB is good value based on its earnings relative to its share price (21.51x), compared to the US market average (41.33x)
P/E vs Market Valuation
CLB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CLB due diligence checks available for Premium users.
Be the first to know about important CLB news, forecast changes, insider trades & much more!
CLB News
Valuation
CLB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
21.51x
Industry
27.37x
Market
41.33x
CLB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CLB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.54x
Industry
2.71x
CLB is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CLB price to earnings growth (PEG)
For valuing profitable companies with growth potential
CLB is good value based... subscribe to Premium to read more.
PEG Value Valuation
CLB's financial health
Profit margin
Revenue
$128.2M
Net Income
$2.2M
Profit Margin
1.7%
CLB's Earnings (EBIT) of $54.29M... subscribe to Premium to read more.
Interest Coverage Financials
CLB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$586.4M
Liabilities
$356.6M
Debt to equity
1.59
CLB's short-term assets ($223.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLB's long-term liabilities ($268.49M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$19.4M
Investing
-$2.4M
Financing
-$18.5M
CLB's operating cash flow ($24.79M)... subscribe to Premium to read more.
Debt Coverage Financials
CLB vs Oil & Gas Equipment & Service Stocks
Core Laboratories Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.